By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KaloBios Pharmaceuticals, Inc. 

260 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-243-3100 Fax: 650-243-3260



Company News
KaloBios (KBIO)' New CEO Distances Himself Even Further from Shkreli With Drug Pricing Promise 4/11/2016 7:00:13 AM
KaloBios (KBIO)'s Loans to Get Out of Bankruptcy Tied to Reducing Martin Shkreli's Stake 3/22/2016 7:16:37 AM
Scorned Biotech KaloBios (KBIO) Taps New CEO in Hopes of Moving Past Martin Shkreli Controversy 3/7/2016 6:34:30 AM
KaloBios (KBIO) Releases Statement Regarding U.S. Trustee Motion 2/2/2016 2:20:41 PM
KaloBios (KBIO) Seeks Judicial Permission to Pay Out Bonuses in Effort to Shake Off Shadow of Martin Shkreli 2/1/2016 8:44:02 AM
KaloBios (KBIO) Withdraws Appeal On Nasdaq Delisting 1/13/2016 6:31:46 AM
KaloBios (KBIO) Announces Board Changes And New Appointments 1/11/2016 10:12:18 AM
The Deal Martin Shkreli was Trying to Complete for KaloBios (KBIO) Before He was Arrested 1/6/2016 6:42:44 AM
KaloBios (KBIO) Notified By Nasdaq Stock Market Of Additional Bases For Delisting 12/31/2015 9:36:22 AM
Martin Shkreli's Former Drugmaker KaloBios (KBIO) Files for Bankruptcy 12/30/2015 6:16:21 AM